EmtinB discussion, page-16

Yes it's holding well, market seems to be patient with this one.

A reminder we are awaiting 3 study reports from 3 different labs this quarter:

- CVN mouse model for Alzheimer's - any indication the drug crosses into the brain and improves cognition in CVN mice is a company maker. The CVN mouse model is still the one that most closely mimics Alzheimer's in humans in terms of behavioural changes, biochemical changes, etc.

- ophthalmology results - in rabbits, expecting the drug to heal severed optic nerves; the MT-II parent has already been proven to do this, so it's very unlikely EmtinB won't achieve the same outcome

- toxicology and safety reports - all good and we are off to human trials

Fingers crossed we get at least one of these this month